Health
Investors With $13 Trillion Urge Climate Approach to Superbugs
- Group seeks science-based target, international framework
- Resistant bacteria pose a “systemic risk” to financial markets
This article is for subscribers only.
Investors with more than $13 trillion in combined assets are calling on global policymakers to set a science-based target to curb the spread of superbugs, drawing inspiration from a similar blueprint used to tackle planet-warming emissions.
Legal & General Investment Management and Aviva Investors are among 80 institutions that have signed an open statement seeking an international framework and scientific panel to address the challenge of bacterial resistance around the globe.